Incidence of non-typhoidal Salmonella invasive disease: a systematic review and meta-analysis, Christian Marchello, University of Otago Complications and mortality of non-typhoidal Salmonella invasive disease: a global… Tweet
We are pleased to announce that the Master in Vaccinology and Drug Development of the University of Siena is now open for applications (academic year 2021-2022). The… Tweet
The Vacc-iNTS training of staff from African countries on serological assays has been held virtually on 5th and 6th November 2020. The theoretical course aimed… Tweet
The Vacc-iNTS Annual Meeting 2020 has been held on 22nd and 23rd October 2020.More than 75 participants from 13 countries and 5 continents have attended… Tweet
We are pleased to announce that the Master in Vaccinology and Drug Development of the University of Siena is now open for applications (academic year 2020-2021). The… Tweet
The Vacc-iNTS consortium, made up of 12 partners from 8 different countries including iNTS disease-endemic countries, met in Siena (Italy) on 24-25th October 2019 for… Tweet
The Vacc-iNTS project for the manufacture and clinical development of a vaccine against invasive non-typhoidal salmonellosis (iNTS) disease funded by the European Commission has started.… Tweet
“FIH Invasive Non-Typhoid Salmonella Trial”, Maheshi Ramasamy, Oxford Vaccine Group. For more details: https://cvnuk.co.uk/ Tweet
Development of a vaccine based on GMMA against invasive nontyphoidal Salmonella disease: towards Phase 1 testing in humans, Vacc-iNTS synergies with ADITEC, Laura B. Martin, GSK… Tweet